Showing results (151-160 of 201) with videos related to
Sort By:
Pageof 21
Cancer|July 5, 2023
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor BoardAjay Gupta, Richard F Riedel, Chirag Shah, et al.Cancer Chemotherapy and Pharmacology|February 27, 2017
Phase I study of pazopanib plus TH-302 in advanced solid tumorsRichard F Riedel, Kellen L Meadows, Paula H Lee, et al.Proceedings of the National Academy of Sciences of the United States of America|March 13, 2009
Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancerDavid S Hsu, Chaitanya R Acharya, Bala S Balakumaran, et al.AJR. American Journal of Roentgenology|October 20, 2021
Dual-Energy CT Vital Iodine Tumor Burden for Response Assessment in Patients With Metastatic GIST Undergoing TKI Therapy: Comparison With Standard CT and FDG PET/CT CriteriaMathias Meyer, Peter Hohenberger, Daniel Overhoff, et al.BMC Cancer|October 16, 2024
Cell-cycle phase progression analysis identifies three unique phenotypes in soft tissue sarcomaMark M Cullen, Alexander L Lazarides, Patricia D Pittman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancerDavid S Hsu, Bala S Balakumaran, Chaitanya R Acharya, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing SarcomaPaul A Meyers, Noah Federman, Najat Daw, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 12, 2010
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumorsGeorge D Demetri, Margaret von Mehren, Cristina R Antonescu, et al.Plos One|December 4, 2009
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytomaJeffrey K Mito, Richard F Riedel, Leslie Dodd, et al.Nature Medicine|October 24, 2006
Genomic signatures to guide the use of chemotherapeuticsAnil Potti, Holly K Dressman, Andrea Bild, et al.Pageof 21